All articles tagged with #weight loss pills
GLP-1 medications, now available as weight‑loss pills, can improve metabolic and cardiovascular health, but their rising visibility risks normalizing the thin ideal and potentially triggering disordered eating; experts emphasize careful screening, multidisciplinary treatment, and that these drugs are not a cure for eating disorders, with long-term effects still largely unknown and resources like NEDA available.
Novo Nordisk has announced a price reduction for its Wegovy weight-loss pill in the US to compete with Eli Lilly's market offerings, initiating a price war in the weight-loss drug industry. The company will offer lower doses at significantly reduced prices, aiming to attract more overweight and obese patients, especially following the recent FDA approval of an oral version of Wegovy. This move comes amid a competitive landscape with Lilly's upcoming drug, orforglipron, expected to be approved soon.
Eli Lilly's shares dropped over 14% after its obesity drug forglipron underperformed expectations in late-stage trials, marking its worst day in decades, while competitors like Novo Nordisk saw gains amid ongoing development of weight loss medications.
Pharmaceutical companies such as Eli Lilly and Pfizer are developing weight-loss pills, which have garnered investor excitement in recent weeks. The focus has shifted from injectables to pills that could arrive in the market in the next few years.